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  The hyperosmotic stimulus is regarded as a mechanical factor for bone remodeling. However, whether 
the hyperosmotic stimulus affects 1α, 25-dihydroxyvitamin D3 (1α,25(OH)2D3)-induced osteoclasto-
genesis is not clear. In the present study, the effect of the hyperosmotic stimulus on 1α,25(OH)2D3- 
induced osteoclastogenesis was investigated in an osteoblast-preosteoclast co-culture system. Serial 
doses of sucrose were applied as a mechanical force. These hyperosmotic stimuli significantly evoked 
a reduced number of 1α,25(OH)2D3-induced tartrate-resistant acid phosphatase-positive multinucleated 
cells and 1α,25(OH)2D3-induced bone-resorbing pit area in a co-culture system. In osteoblastic cells, 
receptor activator of nuclear factor κB ligand (RANKL) and Runx2 expressions were down-regulated 
in response to 1α,25(OH)2D3. Knockdown of Runx2 inhibited 1α,25(OH)2D3-induced RANKL expression 
in osteoblastic cells. Finally, the hyperosmotic stimulus induced the overexpression of TonEBP in osteo-
blastic cells. These results suggest that hyperosmolarity leads to the down-regulation of 1α,25(OH)2D3- 
induced osteoclastogenesis, suppressing Runx2 and RANKL expression due to the TonEBP over-
expression in osteoblastic cells. 
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INTRODUCTION
  Bone is metabolically active tissue that is capable of 
adapting its structure to the mechanical load and repairing 
structural damage through the process of remodeling. Bone 
remodeling is closely coupled with the physiological activ-
ities of osteoblasts and osteoclasts to ensure skeletal in-
tegrity [1-5]. Recently, it was clearly documented that stro-
mal/osteoblastic cells are essential components of the differ-
entiation of monocytes/macrophages into osteoclasts in vitro, 
through expression of the signal molecules needed to pro-
mote osteoclastogenesis: macrophage colony-stimulating 
factor (M-CSF) and the receptor that activates the nuclear 
factor kappa B (NF-κB) ligand (RANKL). RANKL, the os-
teoclast-differentiating factor, binds to RANK on the sur-
face of osteoclast precursor cells [6,7]. In addition, stro-
mal/osteoblastic cells also secrete osteoprotegerin (OPG), 
which inhibits osteoclastogenesis by binding with RANKL 
as a decoy receptor [8]. This RANK/RANKL signaling sys-
tem plays a key role in the development of osteolytic bone 
lesions such as osteoporosis, cancer-associated osteolytic 
diseases, and rheumatoid arthritis [9,10].
  Physiologically, osteoclast development and activity is 
the under the control of osteoblast/stromal cells [11], which 
modulate the RANKL/OPG axis for osteoclastogenesis. 
Parathyroid hormone, prostaglandins, interleukins, vita-
min D3, corticosteroids, and mechanical load are involved 
in osteoclastogenesis. Osteoblast/stromal cells translate all 
these signals into an appropriate RANKL and OPG output 
to control osteoclast differentiation and bone remodeling. 
Therefore, osteoblast/stromal cells are regarded as a trans-
ducer of cytokine/hormone signal for osteoclasts, where in-
put is the cytokine/hormone/mechanical signal and the out-
put is the RANKL/OPG ratio. In addition, skeletal mass 
and architecture are adjusted by the critical and competing 
responsibilities of structural and metabolic factors [12-14]. 
Metabolic demands on bone tissue are processed through 
calciotropic hormones, while structural/mechanical stimuli 
to the skeleton trigger the genetic baseline, and the bone 
adapts to its loading environment by biomechanical signal 
transduction. 
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  Recently, much attention has been focused on how me-
chanical load leads to the biological responses of the bone 
cells as well as numerous cell types, including endothelial 
cells chondrocytes, and fibroblasts [15-19]. The load-in-
duced cellular deformation may play a key role in determin-
ing the cellular biochemical response that occurs at the 
whole-cell level [20], and mechanical loading induces global 
cellular responses such as changes in cell morphology and 
cytoskeletal structure [21,22]. Therefore, mechanical load-
ing is transduced into biological processes, generating de-
formation in the bone tissue continuously exposed to me-
chanical stress including osmotic stress and gravity, pres-
sure in the intramedullary cavity within the cortices, tran-
sient pressure waves, shear forces through canaliculi, and 
even dynamic electric fields as interstitial fluid flows past 
charged bone crystals. In particular, studies with animal 
models have demonstrated that mechanical stimulations 
such as shear stress induce the change in the shape of os-
teoblasts and an increase in intracellular calcium (Ca2＋) 
response [23] and also regulate bone remodeling [24]. 
Mechanical loading causes cell membrane deformation such 
as stretching or folding, which is induced by the hypotonic 
and hypertonic stress, respectively [25]. 
  As a potent regulator of the bone remodeling, osmotic 
stimuli result in the modulation of osteoclastic proliferation 
and/or differentiation, and eventually alters the bone 
resorption. However, a precise mechanism of these osmotic 
stimuli remains to be studied. Here, we investigated wheth-
er the hyperosmotic stimulus in an osteoblast-preosteoclast 
co-culture system leads to changes in 1α, 25-dihydroxy-
vitamin D3 (1α,25(OH)2D3)-induced osteoclastogenesis.
METHODS 
Materials
  Routine cell culture media, dispase, TRIzol were obtained 
from Gibco BRL (Carlsbad, CA, USA). The 1α,25(OH)2D3, 
sucrose, tartrate-resistant acid phosphatase (TRAP) stain-
ing kit, collagenase, and most of the chemicals were pur-
chased from Sigma-Aldrich (St Louis, MO). ICR mice were 
purchased from Samtacho (O-san, Kyung-gi-Do, Republic of 
Korea). Sodium dodecyl sulfate (SDS) was obtained from 
Bio-Rad Laboratories (Hercules, CA, USA). Anti-Runx2 and 
anti-RANKL were purchased from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA). The TonEBP gene and TonEBP an-
tibodies were gifts by Dr. Sang-do Lee, Chungnam National 
University College of Medicine. All other chemicals were 
of the highest grade commercially available.
Preparation of primary osteoblastic cells, bone marrow 
cells, and hyperosmotic culture medium
  Primary osteoblastic cells were prepared from the calvar-
iae of 1-day-old newborn ICR mice using a slightly modified 
version of a method reported elsewhere [26]. The calvarial 
osteoblastic cells were isolated by digestion with 0.2% colla-
genase (Sigma Chemical Co., Ltd., St.Louis, MO, USA) and 
0.1% dispase. The isolated cells were cultured for 4 days 
in α-minimum essential medium (α-MEM) containing 10% 
fetal bovine serum (FBS) and 1% antibiotic-antimycotic 
(100 U/ml penicillin G sodium, 100 μg/ml streptomycin sul-
fate, and 0.25 μg/ml amphotericin B). The bone marrow cells 
were flushed out from femurs and tibiae of 4-week-old ICR 
male mice and cultured overnight in tissue culture dishes 
in α-MEM containing 10 ng/ml of M-CSF. Osteoblastic cells 
(1×104 cells) and bone marrow cells (1×105 cells) were seeded 
and co-cultured in α-MEM supplemented with 1α,25(OH)2D3 
(10 nM), with or without sucrose addition. After 6 days in-
cubation, the cells were fixed, and stained for TRAP using 
the Leukocyte Acid Phosphate Assay Kit (Sigma-Aldrich) 
according to the protocol of the manufacturer. TRAP-pos-
itive multinucleated cells (more than three nuclei) were 
counted as osteoclast. In vitro formation assay of osteoclast 
was repeated four times.
Bone resorption assay using OAAS plates
  The osteoblastic cells and bone marrow cells were co-cul-
tured in α-MEM in calcium phosphate apatite-coated osteo-
clast activity assay substrate (OAAS) plates (Oscotec, Seoul, 
Republic of Korea). After 4 days incubation, the medium 
was replaced with fresh medium containing 1α,25(OH)2D3 
and/or sucrose. After culturing, the attached cells were re-
moved from the plate by the addition of a 4% sodium hypo-
chlorite solution. Images of the pit were captured using a 
digital camera attached to a microscope at ×100 magnifica-
tion, and the total area of the resorption pits was analyzed 
using the Image Meta Morph Program (Universal Imaging, 
Downingtown, PA, USA). The data are presented as means± 
SEM of four samples.
Assessment of cell viability 
  Cell viability was determined using a conventional MTT 
(3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bro-
mide) assay with slight modification [27]. A MTT solution 
(5 mg/ml in phosphate buffered saline; PBS) was added di-
rectly to the assay plates. To dissolve the formazan crystals, 
dimethyl sulfoxide was then added to assay plates and 
mixed. The resulting mixture was examined using a MRX 
spectrophotometer (Dynatech Laboratories, Chantilly, VA, 
USA) at 570 nm. 
Reverse transcription-polymerase chain reaction 
(RT-PCR)
  The expressions of RANKL, OPG, M-CSF, osteoclacin, os-
teopontin, collagen I and β-actin were evaluated by RT-PCR 
using total RNA isolated from murine osteoblastic cells. 
Cells were lysed in TRIzol reagent according to the in-
structions of the manufacturer (Invitrogen). One microgram 
of RNA was reverse-transcribed with RT-&GOTM reverse 
transcriptase (Qbiogene, Carlsbad, CA, USA). The reverse- 
transcribed cDNA was PCR amplified. Primers used for am-
plification of murine RANKL, OPG, M-CSF, osteoclacin, os-
teopontin, collagen I and β-actin gene fragments were 
RANKL (750 bp) (forward): 5’-ATCAGAAGACAGCACTC-
ACT-3’ (reverse): 5’-ATCTAGGACATCCATGCTAATGTTC-3’; 
OPG (636 bp) (forward): 5’-TGAGTGTGAGGAAGGGCGTT-
AC-3’ (reverse): 5’-TTCCTCGTTCTCTCAATCTC-3’; M-CSF 
(395 bp) (forward): 5’-CATGACAAGGCCTGCGTCCGA-3’ 
(reverse 1): 5’-AAGCTCTGGCAGGTGCTCCTG-3’(reverse 2): 
5’-GCCGCCTCCACCTGTAGAACA-3’; β-actin (366 bp) (for-
ward): 5’-GGACTCCTATGGTGGGTGACGAGG-3’ (reverse): 
5’-GGGAGAGCATAGCCCTCGTAGAT-3’; Cbfa1 (Runx2) (for-
ward): 5’-AGCCTCTTCAGCCGAGTGACACC-3’ (reverse): 5’- 
CTGGGCCATGGTTGACGAATTTC-3’; Osteopontin (forward): 
5’-GAGCGGTGAGTCTAAGGAGT-3’ (reverse): 5’-CTAAAT-
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Fig. 1. Effect of hyperosmotic stimulus of sucrose on 1α,25(OH)2D3-induced osteoclast differentiation in a co-culture system. Mouse BMMs
were co-cultured with calvarial osteoblastic cells in the presence of 1α,25(OH)2D3 and the indicated concentration of sucrose. (A) Preosteoclast
cells underwent differentiation into TRAP-positive multinuclear cells in the presence of 1α,25(OH)2D3, and different concentrations of sucrose.
(B) The number of TRAP-positive multinuclear cells was counted. (C) Cell viability was determined by a MTT assay. Results are presented
as the mean values±SEM (n=4; *p＜0.05, **p＜0.001 versus 1α,25(OH)2D3 only). (D) Osteoclasts had bone resorbing activity on calcium 
phosphate apatite-coated plates. (E) Total areas of formation of pit resorption. Osteoclast differentiation was significantly inhibited as 
the increase in sucrose concentration. Bar indicates mean±SEM (n=5; *p＜0.05, **p＜0.001 versus 1α,25(OH)2D3 only).
GCAAAGTAAGGAAC-3’; Osteocalcin (forward): 5’-AAGCA-
GGAGGGCAATAAGGT-3’ (reverse): 5’-AGCTGCTGTGAC-
ATCCCATAC-3’; Collagen 1 (forward): 5’-ACCTTCCTGCG-
CCTAATGTC-3’ (reverse): 5’-TTGGGTTGTTCGTCTGTT-
TC-3’ . The amplification conditions were optimized for each 
pair of primers as follows: 30 s at 95oC and 30 s at 48oC 
(RANKL), 58oC (OPG, M-CSF, Runx2, and β-actin), 59oC 
(osteopontin) or 55oC (osteoclacin, and collagen I), and 1 
min at 72oC. For the genes, 30 cycles of amplification were 
used to generate the probes. Parallel PCR analysis was run 
for the housekeeping gene β-actin to normalize data for 
differences in mRNA quantity and integrity. All primers 
were obtained from BIONEER (Kyung-gi-Do, Republic of 
Korea). PCR products were separated on 1.2% agarose gels 
and stained with ethidium bromide.
Enzyme-linked immunosorbent assay (ELISA)
  A QuantikineⓇ M murine Mouse RANK Ligand kit (R&D 
Systems, Minneapolis, MN, USA) was used to analyze the 
RANKL protein according to the instructions of the 
manufacturer. The intensity of the color of each well in as-
say plates was determined using a microplate reader at 450 
nm. The method used to detect the OPG was the same as 
that used for the RANKL assay.
Western blot analysis
  Osteoblastic cells were harvested and lysed using RIPA 
buffer containing 10 mM Tris-HCl (pH 7.8), 150 mM NaCl, 
1 mM EDTA, 1% NP-40, and protease and phosphatase 
inhibitors. An equal amount of protein was subjected to 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and 
electrotransferred to a nitrocellulose membrane. The fol-
lowing primary antibodies and dilutions were used: RANKL 
polyclonal antibody (pAb) (1：1,000), Runx2 pAb (1：1,000), 
TonEBP pAb (1：2,000), and actin monoclonal Ab (1：2,000). 
The immune complexes were detected using an enhanced 
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chemiluminescence (ECL) detection kit (Amersham Phar-
macia Biotech, Alington Heights, IL, USA).
Transfection of small interfering RNA (siRNA)
  Runx2 and TonEBP synthesis were inhibited using a 
RNA interference technique involving the generation of 
siRNA. In brief, siRNA for Runx2 and TonEBP were an-
nealed with T4 DNA ligase to form a double-stranded DNA 
fragment, and inserted into the psiSTRIKETM vector (Pro-
mega, Madison, WI, USA) by following the manufacture’s 
procedure. Osteoblastic cells were transfected with 4 μg/ml 
Runx2/or TonEBP siRNA using LipofectamineTM 2000 
(Invitrogen) and were selected with 0.2 mg/ml G418. The 
sequence of siRNA for Runx2 [5'-ACCGCTCTGGCGTTT-
AAATGGTTTCAAGA GAACCATTTAAACGCCAGAGCTTT-
TTC-3' (sense), 5’-TGCAGAAAAAGCTCTGGCGTTTAAAT-
GGTTCTCTTG AAACATTTAAACGCCAGAG-3' (anti-sense)] 
or TonEBP [5'-ACCGAGTTCCTGAGATCTTAAATTCAA-
GAG ATTGATCTCAGGAACTCTTTTTC-3' (sense), 5’-TGC-
AGAAAAAGAGTTCCTGAATCTTAAATCTCTTGAATTT 
AAGATCTCAGGAACT-3' (anti-sense)] (Bioneer Oligo Syn-
thesis) were generated by the Promega siDESIGN Center 
(Promega).
Statistical analysis
  Unless otherwise stated, all experiments were repro-
duced at least three times. The results are expressed as 
mean±SE. The statistical significance between comparable 
groups was determined using the Kruskal-Wallis and Bon-
ferroni’s test. In statistical tests, the p-value＜0.05 was con-
sidered significant.
RESULTS
Inhibition of 1α,25(OH)2D3-induced osteoclast formation 
and activity by hyperosmotic stress in a co-culture 
system 
  To provide hyperosmotic stress, 25, 50, 100, 150, and 200 
mM (306, 326, 368, 410, and 460 mOsm) of sucrose were 
added to the co-culture medium, and cells were then in-
cubated at 37oC for 4 days. When 10 nM 1α,25(OH)2D3 was 
added to the co-culture system, 209±19 TRAP-positive mul-
tinucleated cells were formed, whereas no TRAP-positive 
cells were detected in the media alone. However, the 1
α,25(OH)2D3-induced osteoclast formation was reduced in 
response to the addition of sucrose to the co-culture medium 
(Fig. 1A, 1B). The addition of 25 mM or 50 mM sucrose 
lowered the number of multinucleated osteoclast to 78±29 
and 58±20 cells per well, respectively. The addition of su-
crose (25 and 50 mM) did not show any toxic effect when 
added up to 50 mM (Fig. 1C), indicating the inhibitory ef-
fect of the addition of sucrose on osteoclast formation was 
caused by a change in osteoclastogenesis, not by its direct 
toxic effect on the cells. To evaluate osteoclastic activity, 
osteoblastic cells and bone marrow cells were co-cultured 
in α-MEM on OAAS plates coated with carbonated calcium 
phosphate instead of dentin slice [28], and the resorption 
lacuna were then measured for bone resorbing activity. 
No resorption pits were observed on the OAAS plates in 
the absence of 1α,25(OH)2D3, while treating with 10 nM 
1α,25(OH)2D3 produced numerous resorption pits and mul-
tiple lacunae. Additionally, the hyperosmotic stimulus caused 
by the addition of sucrose to the co-culture medium resulted 
in a decrease of the 1α,25(OH)2D3-induced resorption pits 
and area (42±8% of control at 25 mM sucorose, 11±2% of 
control at 50 mM sucrose; Fig. 1D, 1E). These findings in-
dicate that hyperosmotic stimulus (25 and 50 mM sucrose 
addition to co-culture medium) inhibits osteoclast differ-
entiation and osteoclast activity without causing toxic dam-
age to the cell. 
Effects of hyperosmotic stimulus on expression of genes 
for osteoclast differentiation factor and osteoblast marker 
genes in mouse calvarial osteoblasts 
  Fig. 2A shows the expression levels of the genes for osteo-
clast differentiation factor such as RANKL, OPG, and 
M-CSF from osteoblastic cells in the presence of 1
α,25(OH)2D3. Fig. 2B displays the quantified results. The 
expression of mouse RANKL mRNA was remarkably increased 
in the calvarial osteoblastic cells treated with 1α,25(OH)2D3 
alone. However, hyperosmotic stimulus caused by the addi-
tion of sucrose to culture medium resulted in a dose-de-
pendent decrease in RANKL mRNA expression without 
changing the OPG and M-CSF mRNA expression levels in 
the presence of 1α,25(OH)2D3. The effects of hyperosmotic 
stimulus to culture medium on the 1α,25(OH)2D3-induced 
RANKL and OPG protein expressions in osteoblastic cells 
were also quantitatively examined by ELISA using an-
ti-RANKL and anti-OPG antibodies. As shown in Fig. 2C, 
the 1α,25(OH)2D3-induced RANKL protein level was low-
ered with increasing sucrose concentrations. Although the 
OPG levels in osteoblastic cells were slightly elevated by 
the addition of sucrose, this level of upregulation was not 
statistically significant (Fig. 2D). Consequently, hyper-
osmotic stimulus as a result of the addition of sucrose to 
the culture medium inhibited the 1α,25(OH)2D3-induced 
RANKL mRNA and soluble RANKL protein, leading to the 
down-regulation of osteoclastogenesis in a dose-dependent 
manner. 
  The effect of hyperosmotic stimulus on the differentiation 
of osteoblasts was investigated since insufficient osteoclas-
togenesis may occur due to the immaturation of preosteo-
blast cells in a co-culture system. The expression levels of 
the osteoblast marker genes such as collagen I, osteopontin, 
and osteocalcin were examined by RT-PCR in the presence 
of hyperosmotic stimulus (Fig. 2E). The hyperosmotic stim-
ulus as a result of sucrose addition did not cause any dis-
tinct changes in the osteocalcin, osteopontin, and collagen 
I mRNA, which are expressed in the matured osteoblasts. 
These results indicate that hyperosmotic stimulus does not 
affect osteoblast differentiation.
Effect of hyperosmotic stimulus on 1α,25(OH)2D3- 
induced Runx2 expression in calvarial osteoblastic 
cells 
  With respect to the expression of RANKL at the gene lev-
el, Runx2 is involved in osteoclastogenesis at the upstream 
level of RANKL protein, since the basic promoter sequence 
of the RANKL gene contains the binding sites for Runx2 
[30]. Therefore, we examined that the effect of hyperosmotic 
stimulus on 1α,25(OH)2D3-induced Runx2 expression in os-
teoblastic cells. The level of expression of Runx2 in osteo-
blastaic cells was dramatically elevated in response to 10 
nM 1α,25(OH)2D3 compared to that of the control (Fig. 3A). 
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Fig. 2. Effect of hyperosmotic stimulus on the genes of osteoblast. Osteoblastic cells were cultured with 1α,25(OH)2D3 and the indicated 
sucrose concentration. (A) Total RNA was extracted, and then mRNA expression was analyzed by RT-PCR. (B) Bar graph shows the 
quantitative analysis of RANKL/β-actin mRNA. (C, D) For quantitative analysis, sRANKL and OPG productions were determined by ELISA.
The bar graph shows the concentration level of RANKL and OPG protein. (E) Osteoblast marker genes were amplified by RT-PCR using 
RNA the primary osteoblastic cells that were exposed to the hyperosmotic stimulus. Bar represents the mean±SEM (n=4; *p＜0.05 versus
1α,25(OH)2D3 only).
Fig. 3. Effects of hyperosmotic stimulus in 1α,25(OH)2D3-induced Runx2 expression. (A) Western blot analysis of Runx2 expression in 
osteoblastic cells stimulated with 1α, 25(OH)2D3 in the presence of indicated sucrose concentration. (B) Densitometric analysis of Runx2 
and β-actin expression was used to normalize Runx2 data. (C) Western blot analysis of the levels of 1α,25(OH)2D3-induced RANKL and 
Runx2 expression in osteoblastic cells transfected with Runx2 siRNA and selected with G418-neomycine. Bar represents the mean±SEM
(n=6; *p＜0.05, **p＜0.001 versus 1α,25(OH)2D3 only).
However, the hyperosmotic stimulus (25 and 50 mM su-
crose addition) blunted the increase in Runx2 expression 
in a dose-dependent manner (Fig. 3A, 3B). These down- reg-
ulations of RANKL and Runx2 protein suggest that hyper-
osmotic exposure to osteoblastic cells inhibits RANKL ex-
pression via Runx2, eventually interupting osteoclasto-
genesis in the co-culture system. RANKL expression was 
examined after disrupting the Runx2 production using the 
siRNA method. As expected, an upregulated level of 1α,25 
(OH)2D3-induced RANKL expression in mouse calvarial os-
teoblastic cells was abolished to the control level by the 
siRNA-mediated knockdown of Runx2 (Fig. 3C), indicating 
that hyperosmotic stimulus to osteoblastic cells is able to 
decrease 1α,25(OH)2D3-induced RANKL expression via the 
inhibition of Runx2, which in turn leads to the down-regu-
lation of 1α,25(OH)2D3-induced osteoclast differentiation.
TonEBP expression and its modulation in response to 
hyperosmotic stimulus 
  With respect to hyperosmotic stimulus, it has been dem-
onstrated that TonEBP is responsible for transcriptional ac-
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Fig. 4. Changes in the expression of TonEBP and Runx2 by hyperosmotic stimulus. Expression of TonEBP by hyperosmotic stress inhibits
1α,25(OH)2D3-induced RANKL expression in osteoblastic cells. (A) Western blot analysis of TonEBP expression in osteoblastic cells treated
with 1α,25(OH)2D3 and 25 and 50 mM sucrose addition to the culture medium for 2 days. (B) TonEBP was stimulated by hyperosmotic 
stress caused by the addition of sucrose. (C) Western blot analysis of TonEBP expression levels in osteoblastic cells transfected with TonEBP
(overexpression) or TonEBP siRNA. (D) The levels of RANKL expression were analyzed by RT-PCR using osteoblastic cells transfected with 
TonEBP siRNA and TonEBP in the presence or absence of 1α,25(OH)2D3. (E) The down-regulation in Runx2 expression by the stimulation
of TonEBP (in response to the addition of 50 mM sucrose to the culture medium) in osteoblastic cells and TonEBP expression in osteoblastic
cells transfected with Runx2 siRNA. Bar represents the mean±SEM (n=3; *p＜0.05, **p＜0.005 versus 1α,25(OH)2D3 only).
tivation of the genes encoding the regulation of a compat-
ible osmolyte transporter under hyperosmotic conditions in 
kidney cells [29]. Appropriately, an experimented inves-
tigated whether TonEBP could be expressed in osteoblastic 
cells in response to hyperosmotic stimulus, and assessed 
how TonEBP affects 1α,25(OH)2D3-induced osteoclast diffe-
rentiation. Hyperosmotic stimulation caused by the addition 
of sucrose to the culture medium surprisingly led to the 
enhancement of TonEBP expression (3.8∼4.3-fold at 25 and 
50 mM sucrose addition) in osteoblastic cells (Fig. 4A, 4B). 
To clarify how TonEBP works in the process of 1α,25(OH)2D3- 
induced osteoclastogenesis, TonEBP overexpression and si-
lence of TonEBP expression into calvarial osteoblastic cells 
were checked, and also applied in BMMs in the presence 
of 1α,25(OH)2D3. As shown in Fig. 4C, the overexpression 
of TonEBP in osteoblastic cells led to enhancement of the 
TonEBP protein, while silencing of TonEBP resulted in 
attenuation. When TonEBP was overexpressed in the calva-
rial osteoblastic cells, the 1α,25(OH)2D3-induced RANKL 
was suppressed. On the other hand, silence of TonEBP in 
osteoblastic cells caused an increase in 1α,25(OH)2D3-induced 
RANKL expression (Fig. 4D). From these results, it could 
be speculated that the TonEBP gene may be capable of 
down-regulation the RANKL expression by suppressing the 
Runx2 at the upstream level, which in turn leads to in-
hibition of 1α,25(OH)2D3-induced osteoclast differentiation. 
  When osteoblastic cells were cultured in presence of 
1α,25(OH)2D3 plus 50 mM sucrose, the level of TonEBP ex-
pression was dramatically higher than that of expression 
in presence of 1α,25(OH)2D3 only, whereas 1α,25(OH)2D3- 
induced Runx2 expression was reduced to the level of the 
unstimulated condition (no hyperosmotic stimulus; Fig. 
4E). However, this enhancement of TonEBP expression 
caused by hyperosmotic stimulus (addition of 50 mM su-
crose) was maintained even though osteoblastic cells were 
transfected with the Runx2 siRNA (Fig. 4E). These results 
demonstrate that TonEBP down-regulates Runx2 ex-
pression at the downstream level. To further confirm this, 
the effect of TonEBP and Runx2 on osteoclast differenti-
ation was checked in a co-culture system. As shown in Fig. 
1, the number of 1α,25(OH)2D3-induced TRAP-positive mul-
tinucleated cells (169±29 cells) was remarkably decreased 
up to 48±8 cells under hyperosmotic stimulus of 50 mM 
sucrose to the co-culture medium. In addition, the number 
of 1α,25(OH)2D3-induced TRAP-positive multinucleated cells 
was significantly reduced when calvarial osteoblastic cells 
transfected with both Runx2 siRNA and the overexpression 
of TonEBP were co-cultured with BMMs in the presence 
of 1α,25(OH)2D3. Unlike the case of knockdown of Runx2 
by siRNA (61±6 cells), knockdown of TonEBP in osteo-
blastic cells (140±26 cells) did not significantly alter the 
number of 1α,25(OH)2D3-induced TRAP-positive multinu-
cleated cells in co-culture system. 
DISCUSSION
  In the present work, a role of hyperosmotic stimulus in 
regulating osteoclastogenesis, particularly 1α,25(OH)2D3- 
induced osteoclast differentiation in a co-culture system, 
was investigated. Initially, the addition of sucrose to the 
culture medium inhibited 1α,25(OH)2D3-induced osteoclast 
formation in the co-culture system, indicating that hyper-
osmotic stimulus can negatively regulate 1α,25(OH)2D3- in-
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duced osteoclastogenesis (Fig. 1A, 1B). Furthermore, hyper-
osmotic stimulus up to 50 mM sucrose did not change the 
normal cellular viability of the cells in this co-culture sys-
tem (Fig. 1C), and the osteoclasts stimulated by the 1
α,25(OH)2D3 function well on calcium phosphate apa-
tite-coated plates in the co-culture system, inducing the pit 
formation as shown in Fig. 1D. These results support that 
hyperosmotic stimulus induces the alteration of physio-
logical function of the osteoblastic cells, which, in turn, re-
sults in the inhibition of 1α,25(OH)2D3-induced osteoclast 
formation in co-culture system.
  Of the physiological processes linked to osteoclasto-
genesis in osteoblastic cell, we first examined the changes 
in RANKL, M-CSF, and OPG level, which are the key mole-
cules in the osteoblast to modulate osteoclastogenesis. As 
shown in Fig. 2, hyperosmotic stimulus of sucrose to the 
cultured osteoblastic cells lowered the expression level of 
the RANKL mRNA without any significant changes in the 
expression of M-CSF and OPG mRNA. Evidently, the hypero-
smotic stimulus to the osteoblastic cells inhibited 1α,25 
(OH)2D3-induced osteoclastogenesis via the down-regu-
lation of RANKL. To date, the ability of a hyperosmotic 
stimulus to down-regulate 1α,25(OH)2D3-induced RANKL 
expression in osteoblastic cells has not been reported, ex-
cept studies showing the effects of osmotic loading on carti-
lage [31] and intervertebral disc [32]. Few studies have ex-
amined the influence of increasing extracellular glucose on 
osteoblast growth, differenciation, gene expression as well 
as intracellular Ca2＋ change in diabetes [33]. Intriguingly, 
the osmotic stress caused by hyperglycemia in diabetic con-
dition elevates the activator protein 1 (AP-1) level and the 
activity in osteoblasts [34], suggesting that an osmotic stim-
ulus could be a primary inducer of the genetic modulation. 
Such an osmotic effect may be specific to osteoblasts since 
a small addition (4.5∼16.5 mM) of either glucose or man-
nitol can enhance the expression of c-jun and collagen I of 
osteoblast, whereas osteocalcin expression decreases [34]. 
Our results also demonstrate that hyperosmotic stimulus 
by the addition of 25∼50 mM sucrose is sufficient to sup-
press the 1α,25(OH)2D3-induced osteoclast formation and 
pit formation in a co-culture system, down-regulating the 
RANKL expression in osteoblastic cells (Fig. 2). Moreover, 
we confirmed that the osteoblastic cells normally mature 
by expressing the mRNA of the marker genes (osteocalcin, 
osteopontin and collagen 1) when exposed to the hyper-
osmotic stimulus. 
  Based on the facts that the RANKL gene contains func-
tional Runx2-binding sites, and a mutation of these sites 
abrogates the transcriptional activity of the RANKL pro-
moter [30], we examined whether the Runx2 intervenes in 
the upstream of RANKL. In this study, 1α,25(OH)2D3-induced 
Runx2 and RANKL expression in osteoblastic cells were 
lowered as a result of hyperosmotic stimulus of sucrose 
(Fig. 2 and 3), implying that the decrease in Runx2 ex-
pression by hyperosmotic stimulus causes the down-regu-
lation of 1α,25(OH)2D3-induced RANKL expression in os-
teoblastic cells. Additional studies using the osteoblastic 
cells transfected with siRNA of Runx2 demonstrated that 
1α,25(OH)2D3 treatment showed neither enhancement of 
RANKL protein nor decrease in the number of osteoclasts 
in a co-culture system, implicating Runx2 as a crucial factor 
in modulating the RANKL level downstream. Although it 
is still controversial whether Runx2 regulates RANKL ex-
pression in terms of the interrelationship between RANKL 
and Runx2 for cell signaling, it is likely that Runx2 is an 
essential factor in osteoblast differentiation, since the lack 
of osteoclasts in Runx2−/− mice suggests a critical role of 
Runx2 in osteoclastogenesis [35,36]. Overall, Runx2 could 
be essential to osteoclast formation in conjunction with 
RANKL expression, even though it has been reported that 
Runx2 is not responsible for the RANKL expression [37,38]. 
  The next question is how hyperosmotic stimulus leads to 
the decrease in 1α,25(OH)2D3-induced Runx2 expression in 
osteoblastic cells, thus down-regulating the differentiation 
of osteoclasts. Basically, most cells are sensitive to physical 
forces and respond to osmotic stress by activating various 
mechanisms. These processes might involve the coordinated 
organization of the cytoskeleton and the activation of trans-
porters in the plasma membrane that rapidly mediates mo-
bilization of osmotically-active solutes [39]. These changes 
in the intracellular ion concentration, particularly those 
that function as secondary messengers, might influence 
other cellular responses, such as gene expression and cel-
lular metabolism, including the reorganization of the cyto-
skeleton. Of these possible contributors to the hyperosmotic 
effect of the osteoblastic cells, we employed TonEBP, which 
is a transcriptional factor for the cellular accumulation of 
compatible osmolytes under the circumstances of hyper-
osmotic stimulus, because it is reasonable to assume that 
TonEBP is involved in processes affecting tissue hydration 
and osmotic environment, as well as a variety of physiologic 
functions. Our results demonstrate that a hyperosmotic 
stimulus of 50 mM sucrose enhances the expression of 
TonEBP, following the suppression of the Runx2, which, in 
turn, down-regulates 1α,25(OH)2D3-induced RANKL ex-
pression as expected (Fig. 4A, 4B). Additionally, we con-
firmed that the 1α,25(OH)2D3-induced RANKL protein lev-
el was suppressed when TonEBP was overexpressed in the 
calvarial osteoblastic cells, whereas silencing of TonEBP 
caused an increase in 1α,25(OH)2D3-induced RANKL ex-
pression (Fig. 4C, 4D). From the above results, it can be 
speculated that the activation of TonEBP gene by the hy-
perosmotic stimulus suppresses Runx2 expression, possibly 
following the downstream suppression of RANKL 
expression. 
  Our findings suggest that hyperosmotic stimulus leads 
to the down-regulation of 1α, 25(OH)2D3-induced osteoclas-
togenesis, suppressing Runx2 and RANKL expression due 
to the activation of TonEBP expression. Thus, hyperosmotic 
stress could play a pivotal role as a regulator that modu-
lates osteoclastogenesis and bone resorption. 
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